CFTR and infection: Treatment with roscovitine alone, roscovitine plus tezacaftor/ivacaftor, M3 alone or M3 plus tezacaftor/ivacaftor all were associated with a trend towards increased CFTR expression in CF MDMs during infection, but variability was noted within donors (Fig. 4B,C).